Medicine information FIBRYGA 2g powder and solvent for solution for injection / infusion

Product code:
W72188001
Quantity:
1
Indicated for:
bleeding; coagulation disorders
Route of administration:
injectable / infusion
Substance:
human fibrinogen (anticoagulant)
ATC
B02BB01 — Blood and blood forming organs | Vitamin k and other hemostatics | Fibrinogen

Human fibrinogen is an essential blood protein used as a medication to treat or prevent bleeding in patients with fibrinogen deficiency, a rare condition that can be congenital or acquired. Fibrinogen plays a crucial role in blood clotting, helping to form the clots needed to stop bleeding.

Human fibrinogen is administered by intravenous infusion under the strict supervision of medical personnel. The dose and frequency of administration are determined by the doctor, depending on the severity of the deficiency and the patient's needs. Careful monitoring is essential to prevent complications.

Possible side effects include allergic reactions, fever, chills, or an increased risk of blood clots. In rare cases, severe reactions such as anaphylactic shock may occur. If you experience any unusual symptoms, contact your doctor immediately.

Human fibrinogen is vital for patients with bleeding disorders, but its use requires careful medical supervision. Inform your doctor about any other conditions or treatments you are undergoing to reduce the risk of complications.

General data about FIBRYGA 2g

Substance:
human fibrinogen
Date of latest medicines list:
01-10-2026
Product code:
W72188001
Strength:
2g
Pharmaceutical form:
powder and solvent for solution for injection / infusion
Quantity:
1
Product type:
Original
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
OCTAPHARMA AB - SUEDIA
Holder:
OCTAPHARMA (IP) SPRL - BELGIA
Number:
16832/2026/01
Shelf life:
36 months-after packaging for sale;after reconstitution-24h

Strengths available for human fibrinogen

  • 1g
  • 2g

Official documents

Warnings:

Dose adjustment in renal impairment

Dose adjustment may be needed in kidney disease.

Major drug interactions

This medicine may have important interactions with other medicines.

Additional monitoring

This medicine is subject to additional monitoring.

Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning

Use during pregnancy only on medical advice.

Bleeding risk

This medicine may increase the risk of bleeding.